SCHEMBL1680744

SCHEMBL1680744

Clc1cccc(Cc2ccc(C3OCCO3)s2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
TAAR1 Q96RJ0 2/20 0.40
LMNA P02545 1/20 0.39
PNMT P11086 1/20 0.38
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
OPRK1 P41145 1/20 0.37
CCR6 P51684 1/20 0.37
MCOLN3 Q8TDD5 1/20 0.37
MAPT P10636 2/20 0.37
ADAM17 P78536 1/20 0.36
CHRM2 P08172 1/20 0.36
SIGMAR1 Q99720 1/20 0.36
CARM1 Q86X55 1/20 0.35
PRMT6 Q96LA8 1/20 0.35
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ABL1 P00519 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1680499 0.83 TAAR1 (0.40) TAAR1KMT2AMEN1CHRM2CARM1
SCHEMBL1680943 0.82 LTA4H (0.38) NPC1RAB9ALMNAHPGD
Ammonia Solution, Strong SCHEMBL28621254 0.79 NPC1 (0.37) NPC1RAB9ATAAR1LMNAPNMT
SCHEMBL17398402 0.79 NPC1 (0.38) NPC1RAB9ATAAR1LMNAPNMT
SCHEMBL8993057 0.75 LTA4H (0.43) NPC1RAB9ATAAR1PNMTSIGMAR1
SCHEMBL1680485 0.73 ALOX5 (0.36) TAAR1LMNAKMT2AMEN1OPRK1
SCHEMBL1680796 0.72 PNMT (0.39) NPC1RAB9ATAAR1PNMTSIGMAR1
SCHEMBL17398586 0.72 NPC1 (0.40) NPC1RAB9ALMNAKMT2AMEN1
SCHEMBL17398494 0.72 RXFP1 (0.37) NPC1RAB9AMAPTKDM4EHTT
SCHEMBL1680462 0.72 PNMT (0.58) TAAR1LMNAPNMTMAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110195999-A1 NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND NAKAMOTO KAZUTAKA 2011-08-11 US disclosed
US-20110195999-A1 NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND NAKAMOTO KAZUTAKA 2011-08-11 US disclosed
US-20110195999-A1 NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND NAKAMOTO KAZUTAKA 2011-08-11 US disclosed
US-7932272-B2 Antifungal agent containing heterocyclic compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-04-26 US disclosed
US-7932272-B2 Antifungal agent containing heterocyclic compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-04-26 US disclosed
US-7932272-B2 Antifungal agent containing heterocyclic compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-04-26 US disclosed
US-20090227799-A1 Novel Antimalarial Agent Containing Heterocyclic Compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-09-10 US disclosed
US-20070105943-A1 Novel antifungal agent containing heterocyclic compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2007-05-10 US disclosed
US-20070105943-A1 Novel antifungal agent containing heterocyclic compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2007-05-10 US disclosed
US-20070105943-A1 Novel antifungal agent containing heterocyclic compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2007-05-10 US disclosed
EP-1782811-A1 NOVEL ANTIMALARIA AGENT CONTAINING HETEROCYCLIC COMPOUND Eisai R&D Management Co., Ltd. (JP) 2007-05-09 EP disclosed
EP-1669348-A1 NOVEL ANTIFUNGAL AGENT COMPRISING HETEROCYCLIC COMPOUND Eisai Co., Ltd. (JP) 2006-06-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110195999-A1 NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND ERG28, CYP51A1, XPO1 NPC1 170/4885RAB9A 1844/4885TAAR1 2049/4885
US-20090227799-A1 Novel Antimalarial Agent Containing Heterocyclic Compound XPO1, THPO, G6PD NPC1 459/4885RAB9A 391/4885TAAR1 2985/4885
US-20070105943-A1 Novel antifungal agent containing heterocyclic compound ERG28, DPM1, CYP51A1 NPC1 154/4885RAB9A 1739/4885TAAR1 2102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.